Archford Capital Strategies’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Sell
-43
Closed -$2K – 526
2018
Q2
$2K Hold
43
– – ﹤0.01% 574
2018
Q1
$2K Buy
+43
New +$2.52K ﹤0.01% 507
2017
Q2
– Sell
-43
Closed -$3K – 208
2017
Q1
$3K Hold
43
– – ﹤0.01% 524
2016
Q4
$2K Hold
43
– – ﹤0.01% 496
2016
Q3
$2K Sell
43
-43
-50% -$2.04K ﹤0.01% 513
2016
Q2
$4K Buy
+86
New +$3.55K ﹤0.01% 499
2016
Q1
– Sell
-48
Closed -$4K – 187
2015
Q4
$4K Hold
48
– – ﹤0.01% 584
2015
Q3
$2K Buy
48
+24
+100% +$1.58K ﹤0.01% 543
2015
Q2
$2K Buy
+24
New +$1.47K ﹤0.01% 471

Other funds holding ALKS

Archford Capital Strategies's ALKS Position: Q3 2018 in Review

Archford Capital Strategies sold out of Alkermes (ALKS) in Q3 2018, closing a stake of 43 shares — an estimated $2K sold.

Archford Capital Strategies first reported a position in ALKS in Q2 2015 and held it in 9 quarters. The position peaked at $4K in Q2 2016. 262 funds tracked by Wall St. Rank hold ALKS as of Q3 2018.

  • Archford Capital Strategies reported no remaining Alkermes position as of Q3 2018 after selling out during the quarter.
  • Archford Capital Strategies sold 43 Alkermes shares in Q3 2018, an estimated $2K.
  • Archford Capital Strategies first reported a position in Alkermes in Q2 2015 and held it in 9 quarters.
  • Archford Capital Strategies's Alkermes position peaked at $4K in Q2 2016.
  • 262 funds tracked by Wall St. Rank held Alkermes as of Q3 2018.

Based on Archford Capital Strategies's 13F filing for Q3 2018, filed 14 Nov 2018.